← Eichor
Condition: Advanced Soft Tissue Sarcomas Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Soft Tissue Sarcomas

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT04332874Toripalimab Combined With CAV/IE Regimen
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT04589741T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissu
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06474676Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06083883APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Ascentage Pharma Group Inc. · NCT04785196Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Gra
Phase 2 · 22 location(s) · Centre Leon Berard · NCT03624244Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07227571SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Phase 1/Phase 2 · 1 location(s) · Sarcoma Oncology Research Center, LLC · NCT03138161Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07066982Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Phase 2 · 4 location(s) · Niels Junker · NCT05961761Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Phase 2 · 5 location(s) · Italian Sarcoma Group · NCT07328425A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · 54 location(s) · Bayer · NCT06760819QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06939855A Study of Ivonescimab in People With Leiomyosarcoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07516925Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05187338Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 · 25 location(s) · Bristol-Myers Squibb · NCT05245500A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intr
Phase 2 · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT06650514The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06644287XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Tran
Phase 2 · 1 location(s) · Northwestern University · NCT06571734A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Phase 2 · 4 location(s) · Lund University Hospital · NCT06389799X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
Phase 1 · 4 location(s) · Immunolight, LLC · NCT04389281Vebreltinib for Advanced or Metastatic CCS
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07153887A Study of CRD3874-SI in People With Solid Tumors
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06021626Actinium Therapy for Late-stage Aggressive Sarcomas
Phase 1 · 6 location(s) · Ratio Therapeutics, Inc. · NCT07156565Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcom
Phase 1/Phase 2 · 4 location(s) · Grupo Espanol de Investigacion en Sarcomas · NCT05146440Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
Phase 1/Phase 2 · 1 location(s) · University of California, Irvine · NCT07064018A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Phase 1/Phase 2 · 68 location(s) · Turning Point Therapeutics, Inc. · NCT04094610A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Phase 1 · 9 location(s) · Avacta Life Sciences Ltd · NCT04969835EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410676PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04303117
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.